TECH vs TVTX · P/E 65, rev $1.22B vs rev $233.2M
Bio-Techne Corp (TECH) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TVTX revenue for 2024-12-31 was $233.2M. Net income was -$321.5M. Revenue was up 417.5% from 2023-12-31 to 2024-12-31. TVTX currently screens at market cap $1.33B.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the TECH and TVTX stock pages for the full models.
Not investment advice.